Skip to main content
Erschienen in: Allergy, Asthma & Clinical Immunology 3/2010

Open Access 01.11.2010 | Poster presentation

Analysis of Tie2 function in mast cells

verfasst von: Alison Hirukawa, D James Haddon, Frann Antignano, Michael R Hughes, Kelly M McNagny

Erschienen in: Allergy, Asthma & Clinical Immunology | Sonderheft 3/2010

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Background

Mast cells are most widely acknowledged as a central mediator of allergic reactions. Recent literature has also implicated mast cells in a variety of biological and pathological conditions, spurring an interest in the genetic regulation of mast cell function and development. In a survey of global gene expression, we identified higher Tie2 mRNA expression in bone marrow derived mast cells (BMMC) in relation to a Lin-Sca1+cKit+ (LSK) bone marrow population. Tie2 (gene name Tek) is a receptor tyrosine kinase more commonly known for its expression on endothelial cells and a receptor for angiopoietins including Ang1 and 2. Our objective is to explore the function of Tie2 in mast cell development and biology.

Materials and methods

The mRNA level of Tie2 in of BMMC were established via a microarray and confirmed at the protein level through FACS and Western Blot. Mature BMMC were stimulated with Ang1 (200 ng/ml) and probed for phospho-Akt and phospho-Erk. Tie-2 deficient mast cells were derived from Tie2-/- and Tie2+/- embryonic stem (ES) cells, as reported previously [1]. Briefly, embryoid bodies were generated from ES cells and incubated for 14 days, after which the embryoid bodies were dissociated into single cell suspensions and grown in media containing SCF and IL-3.

Results

BMMC express Tie2 mRNA and Tie2 protein at the membrane surface; to our knowledge, this is the first report of Tie2 protein expression in mast cells. Functional analysis and intracellular signaling response following stimulation with Tie2 ligands has revealed that Tie2 is a functionally active Ang1 receptor, as evidenced by activation of Akt and Erk. ES cell derived mast cells (ESMC) can be derived from Tie2-/- and Tie2+/- ES cell lines, and these ESMC do not possess any observable morphological abnormalities.

Conclusions

Given the importance of mast cells in the pathology of human disease, analysis of novel genetic factors regulating mast cell function and development may provide insight into suitable therapeutic targets. To further explore the role of Tie2 in mast cells, future aims include evaluating the ability of Tie2-/- ESMC to reconstitute mast cell-deficient mouse models (eg, Kit W/Wv ) and in vitro assays of Tie2-/- ESMC function such as degranulation and migration.
Open AccessThis article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution 2.0 International License (https://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Literatur
1.
Zurück zum Zitat Tsai M, Tam SY, Wedemeyer J, Galli SJ: Mast cells derived from embryonic stem cells: a model system for studying the effects of genetic manipulations on mast cell development, phenotype, and function in vitro and in vivo. Int J Hematol. 2002, 75: 345-9. 10.1007/BF02982122.PubMedCrossRef Tsai M, Tam SY, Wedemeyer J, Galli SJ: Mast cells derived from embryonic stem cells: a model system for studying the effects of genetic manipulations on mast cell development, phenotype, and function in vitro and in vivo. Int J Hematol. 2002, 75: 345-9. 10.1007/BF02982122.PubMedCrossRef
Metadaten
Titel
Analysis of Tie2 function in mast cells
verfasst von
Alison Hirukawa
D James Haddon
Frann Antignano
Michael R Hughes
Kelly M McNagny
Publikationsdatum
01.11.2010
Verlag
BioMed Central
Erschienen in
Allergy, Asthma & Clinical Immunology / Ausgabe Sonderheft 3/2010
Elektronische ISSN: 1710-1492
DOI
https://doi.org/10.1186/1710-1492-6-S3-P16

Weitere Artikel der Sonderheft 3/2010

Allergy, Asthma & Clinical Immunology 3/2010 Zur Ausgabe

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.